Abstract:Bone loss represents a major unsolved problem in rheumatoid arthritis (RA). The skeletal complications of RA consist of focal bone erosions and periarticular osteoporosis at sites of active inflammation, and generalized bone loss with reduced bone mass. New evidence indicates that osteoclasts are key mediators of all forms of bone loss in RA. TNF-alpha is one of the most potent osteoclastogenic cytokines produced in inflammation and is pivotal in the pathogenesis of RA. Production of tumor necrosis factor-alpha (TNF-alpha) and other proinflammatory cytokines in RA is largely CD4(+) T-cell dependent and mostly a result of interferon-gamma (IFN-gamma) secretion. Synovial T cells contribute to synovitis by secreting IFN-gamma and interleukin (IL)-17 as well as directly interacting with macrophages and fibroblasts through cell-to-cell contact mechanisms. Activated synovial T cells express both membrane-bound and soluble forms of receptor activator of NF-kappaB ligand (RANKL). In rheumatoid synovium, fibroblasts also provide an abundant source of RANKL. Furthermore, TNF-alpha and IL-1 target stromal-osteoblastic cells to increase IL-6, IL-11, and parathyroid hormone-related protein (PTHrP) production as well as expression of RANKL. In the presence of permissive levels of RANKL, TNF-alpha acts directly to stimulate osteoclast differentiation of macrophages and myeloid progenitor cells. In addition, TNF-alpha induces IL-1 release by synovial fibroblasts and macrophages, and IL-1, together with RANKL, is a major survival and activation signal for nascent osteoclasts. Consequently, TNF-alpha and IL-1, acting in concert with RANKL, can powerfully promote osteoclast recruitment, activation, and osteolysis in RA. The most convincing support for this hypothesis has come from in vivo studies of animal models. Protection of bone in the presence of continued inflammation in arthritic rats treated with osteoprotegerin (OPG) supports the concept that osteoclasts mediate bone loss, providing further evidence that OPG protects bone integrity by downregulating osteoclastogenesis and promoting osteoclast apoptosis. Modulation of the RANKL/OPG equilibrium in arthritis may provide additional skeletal benefits, such as chondroprotection. The nexus between T-cell activation, TNF-alpha overproduction, and the RANKL/OPG/RANK ligand-receptor system points to a unifying paradigm for the entire spectrum of skeletal pathology in RA. Strategies that address osteoclastic bone resorption will represent an important new facet of therapy for RA.

Osteogenesis imperfecta and rheumatoid arthritis: connective issues

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons

The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis

Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis

The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders

Cartilage-Related Collagens in Osteoarthritis and Rheumatoid Arthritis: From Pathogenesis to Therapeutics

The Role of Interleukin-17 in Mediating Joint Destruction in Rheumatoid Arthritis

Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression

Bone fragility via degradation of bone quality featured by collagen/apatite micro-arrangement in human rheumatic arthritis

Bone erosions in rheumatoid arthritis: recent developments in pathogenesis and therapeutic implications

The Systemic Immune Response to Collagen-Induced Arthritis and the Impact of Bone Injury in Inflammatory Conditions

Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts

Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases

Collagen transport and related pathways in Osteogenesis Imperfecta

Metabolic and endocrine disease and arthritis

Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review

NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification

Single-cell communication patterns and their intracellular information flow in synovial fibroblastic osteoarthritis and rheumatoid arthritis

Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis

Biomarkers Involved in the Pathogenesis of Hemophilic Arthropathy

Unraveling the genetic collagen connection: clinical and therapeutic insights on genetic connective tissue disorders